Related Experiment Video
Updated: Mar 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Overexpression of SASH1 Inhibits TGF-β1-Induced EMT in Gastric Cancer Cells
1Department of Gastroenterology, Shaanxi Provincial People's Hospital, the Third Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
Abstract:
The epithelial-mesenchymal transition (EMT) is considered to be one of the critical steps in gastric cancer cell invasion and metastasis. SAM- and SH3-domain containing 1 (SASH1), a member of the SLY family of signal adapter proteins, is a candidate for tumor suppression in several cancers. However, the biological role of SASH1 in gastric cancer remains largely unknown. Therefore, the purpose of this study was to investigate the impact of SASH1 on the biological behavior of gastric cancer cells treated with transforming growth factor (TGF)-β1. In the current study, we provide evidence that SASH1 was lowly expressed in human gastric cancer cells, and TGF-β1 also inhibited the expression of SASH1 in TSGH cells. We found that SASH1 inhibited TGF-β1-mediated EMT in TSGH cells, as well as cell migration and invasion. Furthermore, SASH1 obviously inhibited the phosphorylation of PI3K and Akt in TGF-β1-stimulated TSGH cells. In summary, our study is the first to show that overexpression of SASH1 inhibits TGF-β1-induced EMT in gastric cancer cells through the PI3K/Akt signaling pathway. These results suggest that SASH1 may be a potential therapeutic target for the treatment of gastric cancer.
Insights
SAM and SH3 domain-containing 1 (SASH1) suppresses gastric cancer cell invasion. SASH1 inhibits transforming growth factor (TGF)-β1-induced epithelial-mesenchymal transition (EMT) via the PI3K/Akt pathway, suggesting SASH1 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for gastric cancer metastasis.
- SAM and SH3 domain-containing 1 (SASH1) is a potential tumor suppressor, but its role in gastric cancer is unclear.
Purpose of the Study:
- To investigate the effect of SASH1 on gastric cancer cell behavior.
- To determine SASH1's impact on transforming growth factor (TGF)-β1-induced EMT.
Main Methods:
- Assessed SASH1 expression in gastric cancer cells.
- Examined SASH1's effect on TGF-β1-treated gastric cancer cells (TSGH cells).
- Analyzed cell migration, invasion, and PI3K/Akt signaling pathway activity.
Main Results:
- SASH1 expression was low in gastric cancer cells and inhibited by TGF-β1.
- SASH1 suppressed TGF-β1-induced EMT, cell migration, and invasion.
- SASH1 inhibited PI3K and Akt phosphorylation in TGF-β1-stimulated cells.
Conclusions:
- SASH1 inhibits TGF-β1-induced EMT in gastric cancer via the PI3K/Akt pathway.
- SASH1 demonstrates potential as a therapeutic target for gastric cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mitogens and the Cell Cycle

